Pulmonary Artery Sarcoma Study: A Multi-Center ESTS Working Group Evaluating Diagnosis, Treatment, and Outcomes
This study represents the largest reported PAS cohort to date and underscores the diagnostic challenges and poor prognosis associated with this disease. Our findings offer evidence that multimodal treatment provides significant prognostic benefits. However, further prospective studies are warranted to establish standardized diagnostic and therapeutic protocols.
Authors
- Hussein Nasser Awada (ORCID: https://orcid.org/0000-0003-4239-9892)
- Bianca Battilana (ORCID: https://orcid.org/0000-0003-0416-7257)
- B. Moser
- Tom Verbelen (ORCID: https://orcid.org/0000-0003-1461-3986)
- Claudia Lourenço Rodrigues (ORCID: https://orcid.org/0009-0005-1914-1334)
- Ulrike Held (ORCID: https://orcid.org/0000-0003-3105-5840)
- Stefan Schwarz (ORCID: https://orcid.org/0000-0002-3570-0766)
- Marc de Perrot (ORCID: https://orcid.org/0000-0003-2000-9427)
- Olivia Lauk
- K. Chiffi
- M. Haberecker
- Lanuti Michael
- Bedrettin Yildizeli
- Isabelle Opitz
- René Horsleben Petersen
Institutions
- University of Toronto (CA)
- University of Zurich (CH)
- Prevention Institute (US)
- Copenhagen University Hospital (DK)
- Massachusetts General Hospital (US)
- University Hospital of Zurich (CH)
- Marmara University (TR)
- Medical University of Vienna (AT)
- KU Leuven (BE)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1093/ejcts/ezag133
- Primary Topic
- Cardiac tumors and thrombi
- Type
- article
- Field-Weighted Citation Impact
- 0.00